Archive ready
2023年12月期 決算短信〔ＩＦＲＳ〕（連結）
https://ssl4.eir-parts.net/doc/2160/tdnet/2399501/00.pdfMay 4, 2026 at 11:25 AM JST•The archive page, viewer, and downloads use this saved version.
May 4, 2026 at 11:25 AM JST·ssl4.eir-parts.net
The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
Saved PDF
2023年12月期 決算短信〔ＩＦＲＳ〕（連結）
StartedMay 4, 2026 at 11:25 AM JST
File size0.34 MB
SHA-25638323d2ae4df8c5f917adca576931f94afd642f68eb9d84ae2861acbdeb01de7
About this pageAI generated
This document summarizes the financial results for the fiscal year ending December 2023 of GNI Group, Inc. Despite a challenging economic environment, the company achieved record-high revenues of 26,010 million yen and operating income of 13,108 million yen. The strong performance was largely driven by the sales of its main pharmaceutical product, which significantly contributed to revenue growth. The document also outlines forecasts for 2024, indicating continued growth expectations, and discusses future prospects and research and development activities.